Aldeyra Therapeutics (ALDX) Tops Q3 EPS by 5c

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q3 EPS of ($0.32), $0.05 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Hermès can regain momentum despite China weakness, Jefferies says
• Jabil (JBL) Tops Q3 EPS by 8c, Offers Guidance